DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares NASDAQ Listed Jan 27, 2025$10.68
+0.19%
vs $10.66
Mkt Cap $360.1M
52w Low $10.17
100.0% of range
52w High $10.68
50d MA $10.61
200d MA $10.45
P/E (TTM)
52.2x
EV/EBITDA
—
P/B
1.0x
Debt/Equity
0.0x
ROE
-81.8%
P/FCF
-416.1x
RSI (14)
77.80
ATR (14)
$0.01
Beta
-0.00
50d MA
$10.61
200d MA
$10.45
Avg Volume
45.2K
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
1 East Broward Blvd Suite 700 · Fort Lauderdale, FL 33301 · US
Data updated apr 25, 2026 5:26am
· Source: financialmodelingprep.com